- Else Nutrition (BABY) has received a key U.S. patent notice of allowance for use in functional food
- The patent pertains to the composition of Else’s proprietary formulation
- It complements the company’s worldwide patents covering its plant-based toddler and infant formulas and supplemental nutrition for adults
- Else Nutrition develops plant-based food and nutrition products for infants, toddlers, children and adults
- Else Nutrition (BABY) is up by 2.39 per cent and is currently trading at $2.57 per share
Else Nutrition (BABY) has received a key U.S. patent notice of allowance for use in functional food.
The notice indicates that the U.S. Patent and Trademark Office decided to issue the requested patent, which pertains to the composition of Else’s proprietary formulation.
The company already holds worldwide patents covering its plant-based toddler and infant formulas and supplemental nutrition for adults, including patents for the necessary proteins, amino-acids and other nutrients needed in a single food serving.
Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition, stated,
“This development is of monumental importance; it paves the way for future planned product expansion beyond the baby, toddler and kids’ markets. Our 100-per-cent plant-based solution has functional and meaningful applications to a wide range of potential consumer markets.
While we remain laser-focused on the launch of our baby products, our IP can also help serve the rapidly growing US$5 billion U.S. plant-based food market, giving those in need nutritious functional wholefood clean-label offerings.”
Else Nutrition develops plant-based food and nutrition products for infants, toddlers, children and adults.
Else Nutrition (BABY) is up by 2.39 per cent and is currently trading at $2.57 per share as of 1:46 pm ET.
